These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 3470172)
1. Follow-up of colorectal cancer resected for cure. An experience with CEA, TPA, Ca 19-9 analysis and second-look surgery. Fucini C; Tommasi SM; Rosi S; Malatantis G; Cardona G; Panichi S; Bettini U Dis Colon Rectum; 1987 Apr; 30(4):273-7. PubMed ID: 3470172 [TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal cancer follow-up: the effectiveness of sequential CEA, TPA and Ca 19-9 evaluation in the early diagnosis of recurrences. Barillari P; Sammartino P; Cardi M; Ricci M; Gozzo P; Cesareo S; Cerasi A Aust N Z J Surg; 1991 Sep; 61(9):675-80. PubMed ID: 1877936 [TBL] [Abstract][Full Text] [Related]
3. Sensitivity of monoclonal antibodies to carcinoembryonic antigen, tissue polypeptide antigen, alpha-fetoprotein, carbohydrate antigen 50, and carbohydrate antigen 19-9 in the diagnosis of colorectal adenocarcinoma. Alvarez JA; Marín J; Jover JM; Fernández R; Fradejas J; Moreno M Dis Colon Rectum; 1995 May; 38(5):535-42. PubMed ID: 7537651 [TBL] [Abstract][Full Text] [Related]
4. Role of CEA, TPA, and Ca 19-9 in the early detection of localized and diffuse recurrent rectal cancer. Barillari P; Bolognese A; Chirletti P; Cardi M; Sammartino P; Stipa V Dis Colon Rectum; 1992 May; 35(5):471-6. PubMed ID: 1568399 [TBL] [Abstract][Full Text] [Related]
6. The role of CEA, TPA and CA 19-9 in the early detection of recurrent colorectal cancer. Barillari P; Ramacciato G; de Angelis R; Gozzo P; Aurello P; Indinnimeo M; Valabrega S; D'Angelo F; Fegiz G Int J Colorectal Dis; 1989 Dec; 4(4):230-3. PubMed ID: 2693562 [TBL] [Abstract][Full Text] [Related]
7. CEA-directed second-look surgery in the asymptomatic patient after primary resection of colorectal carcinoma. Martin EW; Minton JP; Carey LC Ann Surg; 1985 Sep; 202(3):310-7. PubMed ID: 4037904 [TBL] [Abstract][Full Text] [Related]
8. Limitations of CEA monitoring as a guide to second-look surgery in colorectal cancer follow-up. Fucini C; Tommasi MS; Cardona G; Malatantis G; Panichi S; Bettini U Tumori; 1983 Aug; 69(4):359-64. PubMed ID: 6623661 [TBL] [Abstract][Full Text] [Related]
9. The role of tumour markers (CEA, TPA, CA 19-9) in colon and rectum carcinomas. Cangemi V; Volpino P; Fiori E; Giammarco A; Piat G J Nucl Med Allied Sci; 1987; 31(2):189-93. PubMed ID: 3476692 [No Abstract] [Full Text] [Related]
10. Use of CEA as an indicator of early recurrence and as a guide to a selected second-look procedure in patients with colorectal cancer. Wanebo JH; Stearns M; Schwartz MK Ann Surg; 1978 Oct; 188(4):481-93. PubMed ID: 697433 [TBL] [Abstract][Full Text] [Related]
11. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse. Nicolini A; Caciagli M; Zampieri F; Ciampalini G; Carpi A; Spisni R; Colizzi C Cancer Detect Prev; 1995; 19(2):183-95. PubMed ID: 7750106 [TBL] [Abstract][Full Text] [Related]
12. [Effectiveness of quarterly assessment of CEA, TPA and GICA serum levels in gastric and colorectal carcinomas: Prospective study of 174 patients undergoing radical surgery]. Barillari P; Ricci M; Broglia S; Manetti G; Cerasi A; Cesareo S; Calcaterra D; Cioè I; Caronna R; Sammartino P Minerva Chir; 1994 Oct; 49(10):953-61. PubMed ID: 7808670 [TBL] [Abstract][Full Text] [Related]
13. [Evaluation of combined CA-19-9 and CEA assay in monitoring recurrences and metastases of colorectal cancer]. Yu BM Zhonghua Wai Ke Za Zhi; 1992 Dec; 30(12):707-9, 777. PubMed ID: 1339738 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the tumor markers CEA, TPA, and CA 19-9 in colorectal carcinoma. Putzki H; Student A; Jablonski M; Heymann H Cancer; 1987 Jan; 59(2):223-6. PubMed ID: 3467817 [TBL] [Abstract][Full Text] [Related]
15. Cost effectiveness of postoperative carcinoembryonic antigen monitoring in colorectal cancer. Sandler RS; Freund DA; Herbst CA; Sandler DP Cancer; 1984 Jan; 53(1):193-8. PubMed ID: 6418372 [TBL] [Abstract][Full Text] [Related]
16. Tumor markers carcinoembryonic antigen, tissue polypeptide antigen, and carbohydrate antigen 19/9 in liver diseases. Putzki H; Ledwoch J; Student A; Jablonski M; Heymann H J Surg Oncol; 1988 Feb; 37(2):133-5. PubMed ID: 3278167 [TBL] [Abstract][Full Text] [Related]
17. [Effect of serial CEA determination on diagnosis, therapy and prognosis of recurrent colorectal cancer]. Mentges B Langenbecks Arch Chir; 1988; 373(4):227-34. PubMed ID: 3210846 [TBL] [Abstract][Full Text] [Related]
18. Serial levels of CA 19-9 and CEA in colonic cancer. Novis BH; Gluck E; Thomas P; Steele GD; Zurawski VR; Stewart R; Lavin PT; Zamcheck N J Clin Oncol; 1986 Jun; 4(6):987-93. PubMed ID: 2423655 [TBL] [Abstract][Full Text] [Related]
19. Multivariate analysis of a tissue CEA, TPA, and CA 19.9 quantitative study in colorectal cancer patients. A preliminary finding. Cosimelli M; De Peppo F; Castelli M; Giannarelli D; Schinaia G; Castaldo P; Buttini GL; Sciarretta F; Bigotti G; Di Filippo F Dis Colon Rectum; 1989 May; 32(5):389-97. PubMed ID: 2714130 [TBL] [Abstract][Full Text] [Related]
20. Serum CEA in the follow-up of colorectal carcinoma: experience in a district general hospital. Allen-Mersh TG Ann R Coll Surg Engl; 1984 Jan; 66(1):14-6. PubMed ID: 6691692 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]